TAKE THIS POLL |
|
|
- Thyroid Cancer Helped By Tumor Pill 4 Jul 2008 22:56 GMT
... New Medication Starves Tumors And Aids Cancer Recovery Washington, D.C.- Amgen has created a new pill that is taken once-a-day that works to starve tumors ...
- Monoclonal Antibodies Report Part II - Companies - Holding mAbs in portfolio promises protection against 4 Jul 2008 18:17 GMT
... will have significantly enhanced their presence in the mAb segment, with four companiesBiogen IDEC, Amgen, Novartis and UCB Pharmaeach forecast to generate mAb sales growth in excess of $1 ...
- Amgen's VEGF Inhibitor Motesanib Proves Effective in Thyroid Cancer 4 Jul 2008 16:51 GMT
... in the July 3 issue of the New England Journal of Medicine reveals that Amgen Inc.’s experimental cancer drug, motesanib diphosphate, proved efficient in the case of people suffering ...
- Tour of California may ride in Santa Cruz 4 Jul 2008 11:24 GMT
... front doors. Santa Cruz is a finalist to host a stage of the 2009 Amgen Tour of California pro bike race, city leaders announced Thursday. "We've been pitching ourselves ...
- Orphan drug program continues to yield treatments for serious conditions 4 Jul 2008 04:33 GMT
... to the cost of drugs,” noted Marlene Haffner, previous head of OOPD, now with Amgen. The cost of drugs, she adds, “is a very real issue.” ...
- Affymax wavers on forecast of Hematide approval 4 Jul 2008 04:30 GMT
... believes investors are overlooking the drug's prospects because it is an erythopoesis-stimulating agent, like Amgen Inc.'s Aranesp. Those drugs, which treat anemia caused by kidney disease and chemotherapy, have ...
- S&P 500 ends short session nearly unchanged; Ecolab takes biggest gain, Freddie Mac declines 4 Jul 2008 03:07 GMT
... Shares of Ecolab gained $2.04, or 4.8 percent, to $44.48. Biotechnology company Amgen Inc. gained $2, or 4.1 percent, to $50.84. Family Dollar Stores Inc. added 57 ...
- VLST names new CSO 4 Jul 2008 01:16 GMT
... 2004. Prior to that, Dr Carter was director of research for antibody technologies at Amgen. Dr Carter received a BA in natural sciences from Cambridge University in 1982 and ...
- U.S. Techs Struggle, Crude Oil at $145 4 Jul 2008 01:15 GMT
... with a rise of 8.8% followed by gains in Ecolab Inc of 4.8%, in Amgen Inc of 4.1%, in Liz Claiborne of 4.05%, in Juniper Networks of 4% and ...
- Shares rally after jobs data 3 Jul 2008 22:30 GMT
... (MTG) $7.05 +8.80% Ecolab Inc (ECL) $44.48 +4.81% Juniper Networks, Inc. (JNPR) $22.77 +4.12% Amgen Inc. (AMGN) $50.84 +4.10% S&P 500 - Fallers Certegy Inc (FIS) $20.14 -45.93% Nvidia Corporation (NVDA) ...
- Bio-Pharma Launch Value Maximized Through New Product Commercialization Excellence 3 Jul 2008 20:22 GMT
... New Product Commercialization Excellence. The benchmarking study included such influential companies as Abbott, Allergan, Amgen, AstraZeneca, Bayer, Eli Lilly, Genentech, GSK, Merck and Novartis. Key benchmark metrics and executive ...
- S&P 500 Leaders and Laggards: ECL FRE AMGN FHN FDO 3 Jul 2008 19:56 GMT
... S&P 500 Leaders and Laggards: ECL FRE AMGN FHN FDO NEW YORK (AP) - The ... or 4.8 percent, to $44.48. Biotechnology company Amgen Inc. gained $2, or 4.1 percent, to ...
- Penn National Deal Falls, Yahoo Talks 3 Jul 2008 19:31 GMT
... index with a rise of 3.74% or $073, to $21.66 followed by increases in Amgen Inc of 3.36% or $1.64, to $50.48, in Kohl Corp of 2.97% or $1.22, ...
- Stocks Closed Mixed Going Into Holiday Weekend - U.S. Commentary 3 Jul 2008 18:34 GMT
... sessions to set a monthly closing high. ) were two of the biggest gainers. Amgen closed up 4.1 percent, compared to a 4 percent gain by Sanofi Aventis. Chemical ...
- Amgen Closes At Multi-Month High 3 Jul 2008 18:34 GMT
... All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees ...
- Amgen Pill Useful Against Stubborn Thyroid Cancer 3 Jul 2008 18:30 GMT
... Amgen Pill Useful Against Stubborn Thyroid Cancer WASHINGTON JUL 03, 2008 (Reuters) - Amgen's once-a-day ...
- Nasdaq 100 Leaders and Laggards: AMGN NVDA 3 Jul 2008 18:29 GMT
... nation's unemployment rate held steady at 5.5 percent last month. Shares of biotechnology company Amgen Inc. rose $2, or 4.1 percent, to $50.84. Shares of Juniper Networks Inc., which ...
- Blood Vessel Inhibitor Can Slow Metastatic Thyroid Cancer 3 Jul 2008 17:20 GMT
... has been a completely unmet need." Sherman, colleagues in 10 countries, and scientists from Amgen, which is developing motesanib diphosphate (AMG 706), planned and conducted one of the largest ...
- Colorado Confirmed as Top Bioscience State by National Rankings 3 Jul 2008 16:51 GMT
... 2010, planners expect employment at the Fitzsimons site to reach 19,000 people. In 2006, Amgen said it would fund a $150 million expansion of its manufacturing plant in Boulder.” ...
- Readers Get Short With Me--Over Amgen 3 Jul 2008 15:29 GMT
... " You can't help being negative towards Amgen. You purposely did not mention that if ... about the quickly escalating short interest in AMGN - After reading in my recent post ...
- Berkshire County property sells for $7 million 3 Jul 2008 15:18 GMT
... Adele Binder of Los Angeles. Gordon Binder is the former CEO of pharmaceutical company Amgen. The property includes a Colonial-style home, tennis court, pool, utility sheds and adjacent land ...
- LOCATION INC. 3 Jul 2008 14:58 GMT
... prior to this venture? Jaffe was CFO of Alantos when it was sold to Amgen Inc. for $300 million in 2007. Who is on the board of advisers? . ...
- Amgen Breaks Resistance, Hits 6-Month High 3 Jul 2008 14:37 GMT
... All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees ...
- Opening Glance: Biotech shares open mixed 3 Jul 2008 14:21 GMT
... several key biotechnology stocks performed Thursday: Gilead Sciences Inc., up 5 cents to $51.34. Amgen Inc., up 65 cents to $49.49. Biogen Idec Inc., up 96 cents to $59.32 ...
- Blood Vessel Inhibitor Shows Promise Against Metastatic Thyroid Cancer Researchers Also Find Evidence Tying a Genetic Mutation to Clinical Outcome 3 Jul 2008 13:59 GMT
... has been a completely unmet need.” Sherman, colleagues in 10 countries, and scientists from Amgen, which is developing motesanib diphosphate (AMG 706), planned and conducted one of the largest ...
1 - 25 of 99 next >
News by PR Newswire
|
